Douglas Fambrough Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

Douglas Fambrough is Chief Executive Officer of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 0 shares of DRNA, which is worth approximately $0. The most recent transaction as insider was on Dec 28, 2021, when has been sold 231,431 shares (Common Stock) at a price of $38.25 per share, resulting in proceeds of $8,852,236. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

DOUGLAS FAMBROUGH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 28 2021	SELL Sale (or disposition) back to the issuer	$8,852,236 $38.25 p/Share	231,431 Reduced 100.0%	0 Common Stock
Dec 15 2021	SELL Payment of exercise price or tax liability	$203,491 $38.05 p/Share	5,348 Reduced 2.26%	231,431 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	-	13,750 Added 5.49%	236,779 Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	$575,568 $3.2 p/Share	179,865 Added 44.64%	223,029 Common Stock
Aug 10 2021	BUY Open market or private purchase	$110,500 $22.1 p/Share	5,000 Added 10.38%	43,164 Common Stock
Jan 08 2021	SELL Payment of exercise price or tax liability	$143,443 $23.29 p/Share	6,159 Reduced 14.26%	37,030 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	-	19,950 Added 31.6%	43,189 Common Stock

Also insider at

ONCR

Oncorus, Inc. Healthcare

Director